ARTICLE | Clinical News
TretinoinLF intravenous liposomal all-trans retinoic acid: Began Phase II trial in 80 patients for inducing and sustaining remission after relapse, in collabora
September 18, 1995 7:00 AM UTC
(Shareholders approve Argus merger, see page B2.) ...